{
    "clinical_study": {
        "@rank": "99387", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Determine the effects of bile externalization and antibiotic gut\n      sterilization on the pharmacokinetics of mycophenolate mofetil in patients who have\n      undergone orthotopic liver transplantation.\n\n      II.  Correlate serum concentrations of mycophenolic acid with inosine monophosphate\n      dehydrogenase activity in these patients."
        }, 
        "brief_title": "Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation", 
        "condition": "Graft Versus Host Disease", 
        "condition_browse": {
            "mesh_term": "Graft vs Host Disease"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients begin a mycophenolate mofetil (MMF)-containing regimen within the first 5 days\n      after transplantation.  Patients have blood drawn on postoperative days 7, 21, 42, 70, 98,\n      126, and 154.  Urine is collected on postoperative days 7, 21, and 42.  Patients with T-tube\n      bile externalization also have bile collected on postoperative day 7."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Orthotopic liver or kidney transplant recipients who started on a mycophenolate\n        mofetil-containing immunosuppressive regimen within 5 days after transplant\n\n        Kidney transplant recipients will serve as study controls\n\n        --Prior/Concurrent Therapy--\n\n          -  No concurrent bile acid sequestrants\n\n          -  No mycophenolate mofetil as part of rescue therapy regimen\n\n          -  No concurrent albumin replacement therapy\n\n        --Patient Characteristics--\n\n        Renal: Urine output at least 500 mL/day OR Creatinine less than 2.5 mg/dL\n\n        Other:\n\n          -  Not pregnant\n\n          -  No mental incompetency\n\n          -  No prisoners or parolees HIV negative\n\n          -  No active infection defined as: Temperature above 101 F with WBC greater than\n             12,000/mm3 and left shift OR Two or more positive cultures of a single isolated\n             organism from blood, urine, or sputum"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "December 6, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00007059", 
            "org_study_id": "NCRR-M01RR00046-1404", 
            "secondary_id": [
                "UNCCH-GCRC-1404", 
                "ROCHE-CEL028"
            ]
        }, 
        "intervention": {
            "intervention_name": "mycophenolate mofetil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Mycophenolate mofetil", 
                "Mycophenolic Acid"
            ]
        }, 
        "keyword": [
            "disease-related problem/condition", 
            "graft versus host disease", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599-7070"
                }, 
                "name": "University of North Carolina School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation", 
        "overall_official": {
            "affiliation": "University of North Carolina", 
            "last_name": "Robert E. Dupuis", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00007059"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of North Carolina", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2003"
    }, 
    "geocoordinates": {
        "University of North Carolina School of Medicine": "35.913 -79.056"
    }
}